Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LY900014 to insulin lispro in adults with type 1 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)
  • LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2023-02-08